Citation 11473

MIN,BS: MIYASHIRO,H: HATTORI,M:. (2002). INHIBITORY EFFECTS OF QUINONES ON RNASE H ACTIVITY ASSOCIATED WITH HIV-1 REVERSE TRANSCRIPTASE.. 16(S1)

Citation Details

Title	INHIBITORY EFFECTS OF QUINONES ON RNASE H ACTIVITY ASSOCIATED WITH HIV-1 REVERSE TRANSCRIPTASE.
Authors	MIN,BS: MIYASHIRO,H: HATTORI,M:
Year	2002
Volume	16
Issue	S1

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHOQUINONE,1-4:	ACTIVE
2	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHOQUINONE,1-4:	ACTIVE
3	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHOQUINONE,1-4:	INACTIVE
4	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHOQUINONE,1-4:	ACTIVE
5	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	INACTIVE
6	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
7	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	INACTIVE
8	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-3	ACTIVE
9	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLONE	ACTIVE
10	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLONE	ACTIVE
11	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLONE	ACTIVE
12	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	JUGLONE	ACTIVE
13	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PLUMBAGIN	INACTIVE
14	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PLUMBAGIN	ACTIVE
15	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PLUMBAGIN	INACTIVE
16	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PLUMBAGIN	ACTIVE
17	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ILLIMAQUINONE	ACTIVE
18	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-1	INACTIVE
19	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-1	INACTIVE
20	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-1	INACTIVE
21	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VITAMIN K-1	INACTIVE
22	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	ACTIVE
23	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	ACTIVE
24	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
25	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
26	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
27	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	ACTIVE
28	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
29	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
30	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
31	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
32	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
33	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,ACETYL:SHIKONINLAWSONE	INACTIVE
34	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTHRAQUINONE-2-CARBOXYLIC ACIDEMBELINXYLOQUINONE,PARA:ANTHRAQUINONE	INACTIVE
35	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTHRARUFINEMODINRHEIN	INACTIVE
36	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKONIN,DEOXY:ALKANNIN,ANHYDRO:SHIKOMETABOLIN ASHIKOMETABOLIN B	INACTIVE
37	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SHIKOMETABOLIN CSHIKOMETABOLIN DTANSHINONE I,DIHYDRO:TANSHINONE I	INACTIVE
38	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TANSHINONE VTANSHINONE IICRYPTOTANSHINONEAGASTAQUINONE	INACTIVE
39	RIBONUCLEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	INACTIVE
40	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	ACTIVE
41	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	ACTIVE
42	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	ACTIVE
43	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	INACTIVE
44	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	INACTIVE
45	DNA POLYMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NAPHTHAZARINLAPACHOLAGASTANOL	INACTIVE

Citation 11473

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1